Ferrer, Poirot & Wansbrough

What Ferrer, Poirot & Wansbrough does

Ferrer, Poirot & Wansbrough (operating commercially as Ferrer Poirot Feller) is a Dallas-headquartered plaintiff litigation firm founded in 1981 that represents injured individuals on a nationwide basis. The firm's practice is anchored in pharmaceutical and medical device product liability — handling cases involving dangerous drugs (Ozempic, Wegovy, Zantac, Tepezza, Tylenol, Paraquat), defective medical devices (hernia mesh, transvaginal mesh, IVC filters, CPAP, hip implants, pacemakers, Paragard IUDs), and emerging exposure-based claims such as PFAS/forever chemicals — alongside personal injury, mass tort, multidistrict litigation, sexual assault, and gaming addiction matters. The firm operates exclusively on a contingency fee basis, advancing all investigation, expert witness, and filing costs and collecting attorney fees only upon recovery, and draws case flow from direct consumer intake (24/7 phone, free consultation, lawyerworks.com), attorney referrals from peer firms across all 50 states, and an active content marketing footprint covering drug recalls, medical device risks, and case results. The six-attorney senior team is led by Managing Partner Jesse Ferrer with Partners Joe Poirot and Christina Feller (the latter recognized by Super Lawyers 2025 in Class Action and Mass Torts), Of Counsel Ellen Presby, and Senior Attorneys James Hearon and Yvette Ferrer; the firm additionally maintains a network of expert witnesses (pharmacologists, toxicologists, physicians) and FDA regulatory expertise used to litigate against billion-dollar pharmaceutical and device manufacturers. Reported outcomes include "hundreds of millions" in cumulative gross settlements for drug injury victims and a $1.25M Pradaxa verdict, with municipal opioid and PFAS litigation against 3M and DuPont representing newer growth vectors.

Name

Ferrer, Poirot & Wansbrough

Legal name

Ferrer, Poirot & Wansbrough

Website

https://lawyerworks.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

51–100 employees

Short description

Ferrer, Poirot & Wansbrough is a Dallas-headquartered plaintiff litigation firm founded in 1981 that represents injured individuals nationwide on a contingency fee basis across drug injury, defective medical device, mass tort, PFAS, sexual assault, and personal injury cases.

Ownership category

akta.pro rank

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Contingency Fee Legal Services: The firm operates exclusively on a contingency fee basis. Clients pay no upfront costs for legal services. Attorney fees are only collected if the firm obtains compensation for the client. The firm covers all investigation, expert consultation, and court filing costs upfront.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Ferrer, Poirot & Wansbrough (operating as Ferrer Poirot Feller) is a nationwide plaintiff law firm representing injured individuals and their families in pharmaceutical litigation, defective medical device cases, and personal injury matters. The firm operates exclusively on a contingency fee basis, covering all upfront costs and only collecting attorney fees when compensation is recovered for the client.

Product overview

Ferrer, Poirot & Wansbrough (operating as Ferrer Poirot Feller) is a nationwide tort litigation law firm offering comprehensive legal services for injury victims. The firm's core offerings center on drug injury litigation (handling dangerous drug cases involving Ozempic, Wegovy, Tylenol, Tepezza, and Zantac), defective medical device lawsuits (covering transvaginal mesh, hernia mesh, CPAP, implants, and IVC filters), personal injury representation (auto/truck accidents, birth injuries, wrongful death), PFAS/forever chemicals exposure cases, and sexual assault victim advocacy. The firm operates a nationwide attorney referral program accepting mass tort, toxic tort, multidistrict litigation, municipal opioid litigation, and various product liability cases across all 50 states. The MDL services module enables consolidation of similar federal lawsuits for efficient pretrial proceedings.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Injury Legal Services

Quantifiable outcome

• Hundreds of millions of dollars in gross settlements for drug injury victims
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Motley Rice: National mass tort and catastrophic injury firm with deep pharmaceutical, medical device, and opioid practice areas. Closely comparable business model (contingency-based, MDL-focused, plaintiff-side), and competes for the same pool of drug injury and product liability plaintiffs.
• Simmons Hanly Conroy: Mass tort and class action firm with major practices in pharmaceutical litigation, defective medical devices, and personal injury. Operates on contingency fee model and participates in many of the same MDLs (e.g., hernia mesh, opioids) as Ferrer Poirot Feller.
• Lieff Cabraser Heimann & Bernstein: Plaintiff-side firm handling mass tort, class action, and personal injury cases nationally. Strong overlap in pharmaceutical and product liability MDL participation and similar contingency-fee economics.
• Weitz & Luxenberg: Established mass tort and personal injury firm with major pharmaceutical, medical device, and environmental litigation practices. Competes for similar plaintiff inventory and MDL leadership positions.
• Levin Papantonio Rafferty: Plaintiff mass tort firm with significant pharmaceutical and product liability practices. Similar contingency-fee revenue model and participation in nationwide MDLs make it a direct comparator for scale and case mix.
• Robins Kaplan: Plaintiff firm with major mass tort, class action, and personal injury practices. Overlapping pharmaceutical and medical device litigation work and contingency fee economics.
• Milberg Coleman Bryson Phillips Grossman: Plaintiff-side mass tort and class action firm. Active in pharmaceutical and medical device MDLs that overlap with Ferrer Poirot Feller's case portfolio, with similar fee structures.
• Bernstein Litowitz Berger & Grossmann: Specialized plaintiff firm handling complex class actions, securities, and mass tort cases. Comparable contingency-fee model and participation in high-stakes pharmaceutical and corporate accountability litigation.
• Cohen Milstein Sellers & Toll: Plaintiff firm with mass tort, consumer protection, and class action practices. Overlap in pharmaceutical litigation and MDL participation; comparable contingency economics.

Emerging players

• Pogust Goodhead: Mass tort firm with growing footprint in pharmaceutical and consumer class litigation, including opioids and data privacy. Overlapping MDL involvement but smaller and more recently established than the anchor firm.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/lawyerworks
• YouTubeyoutube.com/user/lawyerworks?feature=watch
• Facebookfacebook.com/LawyerWorks
• LinkedInlinkedin.com/company/ferrer-poirot-wansbrough-feller-daniel

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ferrer, Poirot & Wansbrough